
Profitability, historical returns, and peer comparisons.
According to Alvotech’s latest financial reports and current stock price. The company's current ROE is 76.83%. This represents a change of 306.21% compared to the average of 18.91% of the last 4 quarters.
The mean historical ROE of Alvotech over the last ten years is 41.57%. The current 76.83% ROE has changed 84.82% with respect to the historical average. Over the past ten years (40 quarters), ALVO's ROE was at its highest in in the December 2022 quarter at 56.79%. The ROE was at its lowest in in the December 2021 quarter at -187.12%.
Average
41.57%
Median
56.17%
Minimum
-9.81%
Maximum
90.99%
Discovering the peaks and valleys of Alvotech ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 90.99%
Minimum Annual Increase = -117.47%
Minimum Annual ROE = -9.81%
| Year | ROE | Change |
|---|---|---|
| 2025 | -9.81% | -117.47% |
| 2024 | 56.17% | -5.06% |
| 2023 | 59.17% | -34.98% |
| 2022 | 90.99% | 21.57% |
| 2021 | 74.85% | 281.74% |
| 2020 | 19.61% | Infinity% |
The current ROE of Alvotech (ALVO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
35.18%
5-year avg
54.27%
10-year avg
41.57%
Alvotech’s ROE is less than Teva Pharmaceutical Industries Limited (6.35%), less than Amgen Inc. (85.59%), less than Biogen Inc. (1.86%), less than Regeneron Pharmaceuticals, Inc. (15.07%), less than Amphastar Pharmaceuticals, Inc. (10.11%), less than Amneal Pharmaceuticals, Inc. (131.71%), less than Organon & Co. (22.11%), greater than Harrow Health, Inc. (-103.86%), less than Eton Pharmaceuticals, Inc. (40.13%), less than Collegium Pharmaceutical, Inc. (15.96%),
| Company | ROE | Market cap |
|---|---|---|
| 6.35% | $48.77B | |
| 85.59% | $258.68B | |
| 1.86% | $37.61B | |
| 15.07% | $95.80B | |
| 10.11% | $1.19B | |
| 131.71% | $6.95B | |
| 22.11% | $3.63B | |
| -103.86% | $1.08B | |
| 40.13% | $1.45B | |
| 15.96% | $770.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alvotech using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alvotech or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Alvotech's ROE?
How is the ROE calculated for Alvotech (ALVO)?
What is the highest ROE for Alvotech (ALVO)?
What is the 3-year average ROE for Alvotech (ALVO)?
What is the 5-year average ROE for Alvotech (ALVO)?
How does the current ROE for Alvotech (ALVO) compare to its historical average?